Prokarium Expands R&D Capabilities with London Biofoundry to Deepen Microbial Immunotherapy Pipeline
Prokarium, a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, has entered into an agreement, through Imperial Projects, to work with independent researchers from Imperial College London to develop Prokarium’s next-generation therapeutic candidates, engineered to deliver payloads within the tumor microenvironment.
“Prokarium is designing the perfect bacteria to be the next cancer immunotherapy, and we believe leveraging Salmonella’s unique biology will allow us to combine a powerful innate approach with a tailored adaptive response,” said Kristen Albright, PharmD, Chief Executive Officer of Prokarium. “This agreement will significantly expand our R&D capabilities and will further deepen our immunotherapy pipeline.”
This new multi-year agreement builds on work between Prokarium and London Biofoundry that was initiated in 2020 and will further expand Prokarium’s operations. The team from Imperial’s and SynbiCITE’s London Biofoundry specializes in the design, engineering and functional characterisation of synthetic DNA and organisms.
“Prokarium has uniquely positioned their Salmonella platform as an innovative immunotherapy approach for the treatment of solid tumors, and we are excited to support their efforts in pioneering the cancer treatment paradigm shift from synthetic chemistry to synthetic biology,” said Marko Storch, PhD, Head of Synthetic Biology and Automation. “At the London Biofoundry, we developed a cutting-edge SynBio stack and the expertise to collaborate with researchers and biotechs to advance their R&D. We are thrilled to leverage our leading research capabilities to support the development of Prokarium’s new class of medicines in oncology.”
About the London Biofoundry
The London Biofoundry provides a suite of state-of-the-art robotic equipment and expertise supporting automated end-to-end design, construction, and validation of large gene constructs and biological systems. For more information visit www.londonbiofoundry.org
About Imperial College London
Imperial College London is one of the world's leading universities. The College's 20,000 students and 8,000 staff are working to solve the biggest challenges in science, medicine, engineering and business. Reuters named the College as the UK's most innovative university because of its exceptional entrepreneurial culture and ties to industry. For more information visit http://www.imperial.ac.uk/
About Prokarium
Prokarium is a biopharmaceutical company pioneering the field of microbial immunotherapy. Our pipeline is designed to unlock the next level of immuno-oncology by building on the most recent advances in cancer immunology. Prokarium’s lead program is focused on transforming the treatment paradigm in bladder cancer by orchestrating immune-driven, long-lasting antitumor effects. Prokarium is based in London, UK. For further information, visit https://www.prokarium.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220126005069/en/
Contact information
Contacts
For Prokarium
Kristen Albright
Chief Executive Officer
kristen.albright@prokarium.com
www.prokarium.com
For media
MacDougall Advisors
Matthew Corcoran
+1 781-235-3060
prokarium@macdougall.bio
www.macdougall.bio
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Cessna Citation Ascend Program Continues to Advance With Rollout of First Production Unit15.9.2025 14:00:00 EEST | Press release
Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company, today announced its Cessna Citation Ascend business jet program continues to advance as the first production unit rolled out of the manufacturing facility in Wichita, Kansas. The aircraft is expected to achieve certification from the Federal Aviation Administration later this year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250915961668/en/ Cessna Citation Ascend program continues to advance with rollout of first production unit (Photo credit: Textron Aviation). Employees held a special celebration to mark the major program milestone of the newest Citation business jet in the legendary 560XL series as they continue to design and deliver the best aviation experience for customers. “Today is a big celebration and thank you to everyone who has been a part of building up to this point. It is your craftsmanship that continues to make milestones like this possible,” sai
Trade Republic expands from Brokerage to Wealth Management – Invest into Private Markets from 1 euro. Start of strategic partnership with Apollo and EQT.15.9.2025 13:41:00 EEST | Press release
Trade Republic, Europe's largest savings platform, continues to grow, surpassing 10 million customers, across 18 European markets and more than 150 billion euro in assets under management. Through strategic partnerships with Apollo and EQT, Trade Republic expands its services to offer access to Private Markets. In the coming months, the bank will roll out two additional asset classes, each 30 days apart. "Long-term wealth creation is more than just an ETF savings plan. It's about the combination of various asset classes. Now, we are growing Trade Republic from brokerage into wealth management," says Christian Hecker, Co-Founder of Trade Republic. "Everyone in Europe shall have the opportunity to invest like the very wealthy — simple, secure, and at the lowest possible cost. Following our expansion into banking, with checking accounts and cards, this is the most significant milestone since our founding. With Apollo and EQT, we have secured two of the most important Private Markets manag
Jumpmind Announces Strategic Investment from Lone View Capital15.9.2025 13:00:00 EEST | Press release
Jumpmind, a leading provider of innovative retail technology solutions, announced today that Lone View Capital (“Lone View”), a growth-oriented private equity firm focused on technology and software investments, has made a strategic investment, acquiring a controlling stake in the company. Founded in 2008, Jumpmind was recently recognized as a Leader in the Forrester Wave™ for Point of Service Solutions (Q4 2024). The company’s flagship product, Jumpmind Commerce, is a cloud-native, microservices-based point of service platform that enables retailers to unify digital and in-store experiences, streamline checkout, and deliver more personalized customer interactions. Trusted by leading retailers worldwide, the platform supports device independence, rapid deployment, and highly configurable customer journeys – empowering enterprises to adapt quickly in today’s dynamic retail landscape. Jumpmind was named POS Solution of the Year in the 2025 RetailTech Breakthrough Awards. In addition to i
Ookla Launches Speedtest Certified™ to Provide Definitive Network Verification for Properties15.9.2025 13:00:00 EEST | Press release
Ookla®, a global leader in connectivity intelligence, today announced the launch of Speedtest Certified™, the definitive network connectivity verification program for properties. Leveraging Speedtest®'s globally trusted testing methodology and unrivaled brand recognition, the program answers an increasingly important question: how can property owners prove to consumers that they deliver superior connectivity and are ready to support today's connectivity needs? This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250915248087/en/ Pictured is the official plaque awarded to locations that achieve Speedtest Certified™ status, signifying they have met rigorous standards for outstanding network performance. In an era where reliable internet is non-negotiable for tenants, guests, and employees, the stakes for businesses are high – poor connectivity can impact both the bottom line and customer satisfaction. Speedtest Certified addresses t
The AgreenaCarbon Project Becomes the First Large-Scale Soil Carbon Project to Achieve Verra Verification, Now Issuing 2.3 Million Verified Carbon Credits15.9.2025 11:30:00 EEST | Press release
Agreena, the company powering the global transition to regenerative agriculture, has achieved verification of its AgreenaCarbon Project under Verra’s Verified Carbon Standard (VCS) Program’s VM0042 Improved Agricultural Land Management v2.0 methodology – the first large-scale arable agriculture project to do so. By passing this milestone, Agreena is now issuing 2.3 million Verra-verified carbon credits that are not only readily available, but deliver immediate, measurable climate impact. This follows the project’s successful validation in January 2025. While validation confirms that the project design and methodology meet the requirements of Verra’s VCS Program, verification is the critical next step - confirming, through independent assessment, that the project has delivered measurable climate outcomes as intended. Verra’s VCS Program is the world’s most widely recognised greenhouse gas crediting standard and is approved by the Integrity Council for the Voluntary Carbon Market. Unlike
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom